Sp1116
INFLAMMATORY BOWEL DISEASES
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
Experts in different fields across Latin American review and highlight selected abstracts presented at Digestive Disease Week® (DDW) 2023 in Spanish.
Experts in different fields across Latin American review and highlight selected abstracts presented at Digestive Disease Week® (DDW) 2023 in Spanish.
Presenter
University of Miami Miller School of Medicine
Tracks
Related Products
AGA Unraveling the Link Between Diet and IBD
SOCIETY: AGA
INTRODUCTION
SOCIETY: AGA
SEROLOGICAL DIFFERENCES IN AN INFLAMMATORY BOWEL DISEASE (IBD) TRANS-ANCESTRY COHORT HIGHLIGHTING POPULATION HETEROGENEITY
INTRODUCTION: We aimed to investigate the relationship between consumption of ultra-processed foods (UPFs) and: 1) active symptomatic disease and 2) intestinal inflammation in a cohort of adults living with inflammatory bowel disease (IBD)…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
